Below is Validea's guru fundamental report for TEMPUS AI INC (TEM). Of the 22 guru strategies we follow, TEM rates highest using our P/B Growth Investor model based on the published strategy of ...

Tempus AI (TEM) stock is tanking following a short seller report that raised concerns about the company, its products, and ...

Tempus AI delivered strong Q1 results, driven by the Ambry Genetics acquisition and a major AstraZeneca contract, boosting ...

The latest price target for Tempus AI (NASDAQ:TEM) was reported by B of A Securities on May 20, 2025. The analyst firm set a price target for $68.00 expecting TEM to rise to within 12 months (a ...

Tempus AI Inc TEM shares are trading higher by 7.45% to ... provide tumor mutation profiling through matched normal sequence analysis for patients with solid organ neoplasms.

TEM Tempus AI, Inc. 66.04 + 0.26% Summary News Research Chart Community Statistics ... Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...